Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zocor Sales To Take $500 Mil. Hit In 2003 From Merck Inventory Program

Executive Summary

Merck's change in inventory management practices will reduce Zocor sales in 2003 by $500 mil

You may also be interested in...



Merck Sales Force More Focused, Not Smaller, After Vioxx Withdrawal

Merck sales reps will detail fewer products to fewer doctors under a reorganized structure, the company told analysts during its investor day Dec. 14

Merck Sales Force More Focused, Not Smaller, After Vioxx Withdrawal

Merck sales reps will detail fewer products to fewer doctors under a reorganized structure, the company told analysts during its investor day Dec. 14

Cardinal, McKesson Issue Ultimatum: March 31 Deadline For Manufacturers

McKesson and Cardinal are threatening to cut off manufacturers who do not agree to fee-for-service contracts by March 31

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042720

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel